HPLC purity
Target specification: ≥99% area purity by reverse-phase HPLC with UV detection; actual acceptance criteria and result are confirmed for the applicable product and lot.
Vial illustrations reflect supplied lyophilized format. Lot codes are sample identifiers; production lots carry their own batch references.
| Compound | Sermorelin (GHRH 1-29) |
|---|---|
| Synonyms | GRF (1-29), Geref |
| Molecular weight | ≈ 3357.9 g/mol |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 5 mg, 10 mg |
| Documentation | Batch-document availability confirmed by product, specification and applicable lot |
| Storage | 2–8 °C protected from light; long-term −20 °C |
| Tier | Quantity | Lead time |
|---|---|---|
| Sample lot | 1 kit (10 vials) | 3–7 days |
| Production lot | 200–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Sermorelin searches were up 233% YoY in 2025 — research organization demand is real. Add it to the Quote Cart for a precise reply within 4 business hours.
Documentation
COA, HPLC chromatogram, MS identity confirmation, water content and storage notes. Buyer track and destination are confirmed before invoicing.
Target specification: ≥99% area purity by reverse-phase HPLC with UV detection; actual acceptance criteria and result are confirmed for the applicable product and lot.
Mass spectrometry confirmation against the sermorelin (GHRH 1-29) reference profile.
Lot code printed on vial label and reflected in the document pack. Reorders cite prior lot for continuity.
FAQ
Sermorelin is a 29-amino-acid GHRH analog studied in growth-hormone-axis research. Qualified B2B research buyers and private-label brand owners source lyophilized sermorelin for laboratory evaluation.
Sample lots from 1 kit (10 vials); production lots from 200 vials with tier pricing. Repeat OEM orders are scheduled in 1,000-vial batches.
Research organization and wellness-channel procurement interest has expanded as B2B research buyer and research programs evaluate documented peptide supply options. Sermorelin search volume tracked +233% YoY in 2025 reporting.
Yes. Neutral or branded labels, carton design, document packs, and lot-code handling for repeat OEM supply. See the OEM service path for the full process.
Yes — qualified B2B research buyers receive context-specific documentation. We do not supply regulated outsourcing facilities for compounds restricted under the FDA's 2026 regulatory bulk-substance framework proposal.
Related compounds
COA library search
The public COA library is being expanded by product and specification. Use the search link below to check current public records for this item.